Riluzole in Huntington's Disease

Clinical trial NCT00277602 · COMPLETED

Trial details

NCT number: NCT00277602
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Huntington Disease

Start date: 1999-11-01
Primary completion: 2004-07-01
Enrollment: 537

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.